Companion Diagnostics Market Size is estimated to grow at a CAGR of 20.0% during the forecast period
The global companion diagnostics market is
projected to witness growth at a CAGR of 20.0% during the forecast period of
2022-2030.
An in vitro medical device known as a companion diagnostic
is used in conjunction with a therapeutic drug to evaluate the impact and
applicability of the medicine on patients. In order to give safe and efficient
medical treatment, it makes use of a variety of tests and therapies to provide
vital information regarding comparable medicinal medications or biological
products. These diagnostics also give medical practitioners a thorough
understanding of disease biology and the mechanism of action (MOA), which helps
them assess any dangers or side effects that a therapeutic product might have
on particular human bodies.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/companion-diagnostics-market
GROWTH DRIVERS:
Companion diagnostics are increasingly important in drug
development due to a number of benefits they provide. Other factors include the
growing demand for in-vitro diagnostics and targeted therapies, the rising
demand for next-generation sequencing, the rising number of clinical trials,
the growing development of new biomarkers for various diseases, and the rising
cases of adverse drug reactions related to companion diagnostics.
Additionally, the number of alliances and partnerships
amongst top market players for the creation of novel companion diagnostics
products is rapidly rising. The worldwide companion diagnostics market is
expected to experience significant expansion in the coming years as a result of
such corporate partnerships aimed at improving biomarkers and diagnostics.
However, it is anticipated that throughout the projection
period, factors such as a lack of qualified specialists, high costs for
companion diagnostics, and the existence of strict government laws for product
approvals will limit the market's growth to some extent.
COMPANION DIAGNOSTICS MARKET SEGMENTATION:
By Product & Services:
· Assay
Kits & Reagents
· Software
& Services
By Technology:
· Polymerase
Chain Reaction (PCR)
· In
Situ Hybridization (ISH)
· Next-Generation
Sequencing (NGS)
· Immunohistochemistry
(IHC)
· Others
By Indication:
· Cardiovascular
· Neurological
Diseases
· Cancer
o Breast
Cancer
o Lung Cancer
o Colorectal
Cancer
o Melanoma
o Gastric
Cancer
o Infectious
Diseases
o Others
By End User:
· Pharmaceutical
& Biopharmaceutical Companies
· Reference
Laboratories
· Contract
Research Organizations
· Others
By Region:
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East & Africa
KEY COMPANIES IN COMPANION DIAGNOSTICS MARKET:
· Hoffmann-La
Roche AG
· Agilent
Technologies Inc.
· Biogenex
Laboratories Inc.
· Abbott
Laboratories Molecular Inc.
· ARUP
Laboratories Inc.
· BioMerieux
SA
· Danaher
Corporation
· Foundation
Medicine Inc.
· Almac
Group
· Sysmex
Corporation
· Thermo
Fisher Scientific Inc.
· Abnova
Corporation
· Guardant
Health Inc.
· Icon
Plc
· Myriad
Genetics Inc.
· Qiagen
N.V.
For
More Information about this Report @ https://www.xresearch.biz/shop/companion-diagnostics-market
About
Us: -
xResearch is a market research and consulting organization
that uses unique data, expert analysis, and new technologies to create trusted
intelligence on industries. Our research is focused on delivering an informed
and impartial view on essential market data of industry, and it is primarily
driven by an in-depth study covering the following parameters: Market Sizing
and Forecasting, Market Segmentation, Competitive Analysis, Strategic
Assessment and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545

Comments
Post a Comment